These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28669815)

  • 1. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.
    Yang Q; Bavi P; Wang JY; Roehrl MH
    J Proteomics; 2017 Sep; 168():53-65. PubMed ID: 28669815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of antibody-inducing immunogens in tumor tissue identifies PSMA1, LAP3, ANXA3, and maspin as colon cancer markers.
    Yang Q; Roehrl MH; Wang JY
    Oncotarget; 2018 Jan; 9(3):3996-4019. PubMed ID: 29423100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Zhou SN; Pan WT; Pan MX; Luo QY; Zhang L; Lin JZ; Zhao YJ; Yan XL; Yuan LP; Zhang YX; Yang DJ; Qiu MZ
    Dig Dis Sci; 2021 Feb; 66(2):474-482. PubMed ID: 32193860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of β1 integrin expression in colorectal liver metastases.
    Vassos N; Rau T; Merkel S; Feiersinger F; Geppert CI; Stürzl M; Hohenberger W; Croner RS
    Int J Clin Exp Pathol; 2014; 7(1):288-300. PubMed ID: 24427350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural changes of tumor microenvironment in liver metastases of colorectal carcinoma].
    Giuşcă SE; Carasevici E; Eloae-Zugun F; Târcoveanu E; Căruntu ID
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):165-73. PubMed ID: 18677922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.
    Philip R; Murthy S; Krakover J; Sinnathamby G; Zerfass J; Keller L; Philip M
    J Proteome Res; 2007 Jul; 6(7):2509-17. PubMed ID: 17547437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
    Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
    Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.
    Naba A; Clauser KR; Whittaker CA; Carr SA; Tanabe KK; Hynes RO
    BMC Cancer; 2014 Jul; 14():518. PubMed ID: 25037231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.
    Zhao L; Lim SY; Gordon-Weeks AN; Tapmeier TT; Im JH; Cao Y; Beech J; Allen D; Smart S; Muschel RJ
    Hepatology; 2013 Feb; 57(2):829-39. PubMed ID: 23081697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
    Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
    J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCC1 expression in advanced colorectal cancer and matched liver metastases.
    Olsen LM; Fiehn AK; Hasselby JP
    Pathol Res Pract; 2020 Mar; 216(3):152826. PubMed ID: 32008866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
    Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive markers of colorectal cancer liver metastases.
    Govindarajan A; Paty PB
    Future Oncol; 2011 Feb; 7(2):299-307. PubMed ID: 21385143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
    Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
    Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fatty acid-binding protein is a new prognostic factor for hepatic resection of colorectal cancer metastases.
    Yamazaki T; Kanda T; Sakai Y; Hatakeyama K
    J Surg Oncol; 1999 Oct; 72(2):83-7. PubMed ID: 10518104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
    Jang BG; Lee BL; Kim WH
    Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.